IL-17D promoted primary tumor growth in a subcutaneous tumor model, whereas it did not affect lung cancer cell proliferation in vitro, indicating that IL-17D might promote tumorigenesis by influencing the tumor immune microenvironment. Here, IL17D is linked to neoplasm.